These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33692213)

  • 1. Iminosugar Glucosidase Inhibitors Reduce Hepatic Inflammation in Hepatitis A Virus-Infected
    Misumi I; Li Z; Sun L; Das A; Shiota T; Cullen J; Zhang Q; Whitmire JK; Lemon SM
    J Virol; 2021 May; 95(11):e0005821. PubMed ID: 33692213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.
    Das A; Hirai-Yuki A; González-López O; Rhein B; Moller-Tank S; Brouillette R; Hensley L; Misumi I; Lovell W; Cullen JM; Whitmire JK; Maury W; Lemon SM
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A in
    Shiota T; Matsuda M; Zheng X; Nagata N; Ishii K; Suzuki R; Muramatsu M; Takimoto K; Hanaki KI; Lemon SM; McGivern DR; Hirai-Yuki A
    J Virol; 2022 Dec; 96(23):e0149622. PubMed ID: 36354341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis.
    Li Y; Misumi I; Shiota T; Sun L; Lenarcic EM; Kim H; Shirasaki T; Hertel-Wulff A; Tibbs T; Mitchell JE; McKnight KL; Cameron CE; Moorman NJ; McGivern DR; Cullen JM; Whitmire JK; Lemon SM
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2204511119. PubMed ID: 35867748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.
    Warfield KL; Plummer EM; Sayce AC; Alonzi DS; Tang W; Tyrrell BE; Hill ML; Caputo AT; Killingbeck SS; Beatty PR; Harris E; Iwaki R; Kinami K; Ide D; Kiappes JL; Kato A; Buck MD; King K; Eddy W; Khaliq M; Sampath A; Treston AM; Dwek RA; Enterlein SG; Miller JL; Zitzmann N; Ramstedt U; Shresta S
    Antiviral Res; 2016 May; 129():93-98. PubMed ID: 26946111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection.
    Sun L; Feng H; Misumi I; Shirasaki T; Hensley L; González-López O; Shiota I; Chou WC; Ting JP; Cullen JM; Cowley DO; Whitmire JK; Lemon SM
    J Hepatol; 2023 Feb; 78(2):271-280. PubMed ID: 36152761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
    Sasaki-Tanaka R; Shibata T; Moriyama M; Okamoto H; Kogure H; Kanda T
    J Virol; 2022 Sep; 96(18):e0064622. PubMed ID: 36040176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response.
    Sayce AC; Martinez FO; Tyrrell BE; Perera N; Hill ML; Dwek RA; Miller JL; Zitzmann N
    Immunology; 2021 Nov; 164(3):587-601. PubMed ID: 34287854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo therapeutic protection against influenza A (H1N1) oseltamivir-sensitive and resistant viruses by the iminosugar UV-4.
    Stavale EJ; Vu H; Sampath A; Ramstedt U; Warfield KL
    PLoS One; 2015; 10(3):e0121662. PubMed ID: 25786028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-specific antiviral activity of iminosugars against human influenza A viruses.
    Hussain S; Miller JL; Harvey DJ; Gu Y; Rosenthal PB; Zitzmann N; McCauley JW
    J Antimicrob Chemother; 2015 Jan; 70(1):136-52. PubMed ID: 25223974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication.
    Clarke EC; Nofchissey RA; Ye C; Bradfute SB
    Glycobiology; 2021 May; 31(4):378-384. PubMed ID: 32985653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iminosugars: Promising therapeutics for influenza infection.
    Tyrrell BE; Sayce AC; Warfield KL; Miller JL; Zitzmann N
    Crit Rev Microbiol; 2017 Sep; 43(5):521-545. PubMed ID: 27931136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus.
    Miller JL; Hill ML; Brun J; Pountain A; Sayce AC; Zitzmann N
    Antiviral Res; 2019 Oct; 170():104551. PubMed ID: 31306674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
    Durantel D; Branza-Nichita N; Carrouée-Durantel S; Butters TD; Dwek RA; Zitzmann N
    J Virol; 2001 Oct; 75(19):8987-98. PubMed ID: 11533162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
    Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J
    Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo.
    Warfield KL; Warren TK; Qiu X; Wells J; Mire CE; Geisbert JB; Stuthman KS; Garza NL; Van Tongeren SA; Shurtleff AC; Agans KN; Wong G; Callahan MV; Geisbert TW; Klose B; Ramstedt U; Treston AM
    Antiviral Res; 2017 Feb; 138():22-31. PubMed ID: 27908828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells protect against hepatitis A virus infection and limit infection-induced liver injury.
    Misumi I; Mitchell JE; Lund MM; Cullen JM; Lemon SM; Whitmire JK
    J Hepatol; 2021 Dec; 75(6):1323-1334. PubMed ID: 34331968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects.
    Callahan M; Treston AM; Lin G; Smith M; Kaufman B; Khaliq M; Evans DeWald L; Spurgers K; Warfield KL; Lowe P; Duchars M; Sampath A; Ramstedt U
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010636. PubMed ID: 35939501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.